[1]
Szkultecka-Debek, M. et al. 2014. An analysis of potential costs of adverse events based on Drug Programs in Poland. Pulmonology focus. Current Issues in Pharmacy and Medical Sciences. 27, 1 (May 2014), 32–36. DOI:https://doi.org/10.2478/cipms-2014-0009.